| 000 | 01715 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516044903.0 | ||
| 264 | 0 | _c20110906 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1537-6613 | ||
| 024 | 7 |
_a10.1093/infdis/jir270 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHolmes, Natasha E | |
| 245 | 0 | 0 |
_aAntibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations. _h[electronic resource] |
| 260 |
_bThe Journal of infectious diseases _cAug 2011 |
||
| 300 |
_a340-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBacteremia _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xdrug therapy |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVancomycin _xtherapeutic use |
| 700 | 1 | _aTurnidge, John D | |
| 700 | 1 | _aMunckhof, Wendy J | |
| 700 | 1 | _aRobinson, James O | |
| 700 | 1 | _aKorman, Tony M | |
| 700 | 1 | _aO'Sullivan, Matthew V N | |
| 700 | 1 | _aAnderson, Tara L | |
| 700 | 1 | _aRoberts, Sally A | |
| 700 | 1 | _aGao, Wei | |
| 700 | 1 | _aChristiansen, Keryn J | |
| 700 | 1 | _aCoombs, Geoffrey W | |
| 700 | 1 | _aJohnson, Paul D R | |
| 700 | 1 | _aHowden, Benjamin P | |
| 773 | 0 |
_tThe Journal of infectious diseases _gvol. 204 _gno. 3 _gp. 340-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/infdis/jir270 _zAvailable from publisher's website |
| 999 |
_c20994828 _d20994828 |
||